Last reviewed · How we verify

NCT05483842

Reiki Effects on Heart Rhythm, Biochemistry and Cortisol Findings, and Anxiety

Completed NA Last updated 2 August 2022
What this trial tests

NA trial testing Reiki in Anxiety in 66 participants. Completed in 25 July 2022.

Timeline
13 April 2022
Primary endpoint
30 June 2022
25 July 2022

Quick facts

Lead sponsorAnkara Medipol University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment66
Start date13 April 2022
Primary completion30 June 2022
Estimated completion25 July 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Medipol University

Who can join

18 and older, any sex, with Anxiety or Heart Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the effects of Reiki, which is a complementary and traditional method, on heart rhythm, biochemistry and cortisol findings, and anxiety in individuals with arrhythmia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Is Reiki effective in reducing heart rhythm, cortisol levels, and anxiety and improving biochemical parameters in individuals with cardiac disease? Randomized placebo-controlled trial.
    Bektas Akpinar N, Ozcan Yüce U, Cansız G, Yurtsever D, et al · · 2024 · cited 2× · PMID 38652801 · DOI 10.1093/eurjcn/zvae051

Verify or expand the search:

Other trials of Reiki

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Ankara Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483842.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing